John P Sharp Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

PHAS Quotes by TradingView

John P Sharp is Chief Financial Officer of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 65,767 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 20, 2022, when has been sold 6,026 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $4,098. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.8K
0% 3M change
0% 12M change
Total Value Held $0

John P Sharp Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2022
BUY
Grant, award, or other acquisition
$4,098 $0.68 p/Share
6,026 Added 8.39%
65,767 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
$4,054 $2.01 p/Share
2,017 Added 3.27%
59,741 Common Stock
Nov 03 2021
BUY
Exercise of conversion of derivative security
$12,600 $1.68 p/Share
7,500 Added 11.5%
57,724 Common Stock
Aug 03 2021
BUY
Grant, award, or other acquisition
$12,600 $1.68 p/Share
7,500 Added 12.99%
50,224 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
$3,973 $2.8 p/Share
1,419 Added 3.21%
42,724 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
$3,915 $3.0 p/Share
1,305 Added 3.06%
41,305 Common Stock
JPS

John P Sharp

Chief Financial Officer
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAS